Managing Adverse Effects
Active Resources: 8
-
The NHC offers free online continuing education for novice-to-expert health professionals, students, and faculty.
Type: Online and Self-Paced LearningPublish Date: 9/14/2020 -
Slides from a 1-day course for primary care physicians and mid-level clinicians, which combines the latest research with current treatment guidelines for managing patients with HIV.
Type: Training MaterialsPublish Date: 7/31/2020 -
Three sets of training slides covering what providers treating people with HIV should know about COVID-19.
Type: Training MaterialsPublish Date: 4/9/2020 -
Recommended management strategies for HIV patients experiencing virologic failure (VF) while taking antiretroviral therapy (ART).
Type: Training MaterialsPublish Date: 1/31/2020 -
Excerpt from the Guidelines Introduction: "The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is a working group of
Type: GuidelinesPublish Date: 12/18/2019 -
This glossary of HIV/AIDS-related terms includes brief lay-oriented descriptions and illustrations. Materials are in the public domain and may be used freely.
Type: Clinical Reference ToolsPublish Date: 2/20/2019Review Date: 2/20/2019 -
This Fact Sheet Series is from the AIDSinfo/infoSIDA website. It reviews some of the major side effects of anti-HIV medications.
Including:
Type: Clinical Reference ToolsPublish Date: 10/9/2017 -
Type: Online and Self-Paced LearningPublish Date: 2/1/2017
Archive Resources: 2
-
Upon watching this video viewers will :
Type: Online and Self-Paced LearningPublish Date: 4/1/2015 -
AETC HIV and Aging Workgroup
HIV and Aging ToolkitType: Clinical Reference ToolsPublish Date: 4/1/2015
Articles: 5
-
Weight Gain and Metabolic Complications with ART: Data from AIDS 2020
Over the past few years, numerous studies have examined weight gain in people with HIV who start or change antiretroviral therapy (ART). While it is clear that some people gain excessive amounts of weight after starting (and sometimes upon changing) ART, the roles of specific antiretroviral (ARV...
-
Safety of Dolutegravir at Conception: Updated Data
In 2018, initial results from the Tsepamo study of birth outcomes in Botswanan women treated with ART during pregnancy raised questions about the safety of dolutegravir (DTG) when given at the time of conception or very early in pregnancy. Specifically, an early interim analysis found a higher...
-
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference
Highlights from Laura W. Cheever, MD, ScM, HRSA HIV/AIDS Bureau Associate Administrator and Conference Co-Chair
The field of HIV/AIDS care and treatment continues to evolve rapidly. Groundbreaking developments in HIV research are regularly presented at international meetings and...
-
Switching from TDF/FTC to TAF/FTC
Researchers at the 2016 Conference on Retroviruses and Opportunistic Infections presented results from a randomized double-blind, double-dummy switch study of TAF/FTC. Over 660 patients with virologic suppression on TDF/FTC-containing 3-drug regimens were either switched to TAF/FTC (200/10 mg...
-
Cobicistat and Stribild Use in Patients with Renal Insufficiency
Co-Author: Susa Coffey, MD; Medical Editor, AETC National Resource Center
An open-label study is evaluating the renal safety of elvitegravir/cobicistat/emtricitabine/tenofovir (Stribild, or the "quad" pill) and cobicistat. For those patients with mild-to-moderate...